Craig Bowe

Craig Bowe has over 20 years of work experience in the pharmaceutical industry. Craig has held various roles in CMC (Chemistry, Manufacturing, and Controls) and technical operations. Currently, they are the Executive Director of CMC and Technical Operations at Kura Oncology, Inc. Previously, they worked as a CMC Consultant, providing support in contract manufacturing and analytical activities for multiple companies. Craig also served as the Director of CMC and Technical Operations at Celgene. Prior to that, they held positions at AnaptysBio, Receptos, Inc., Orexigen Therapeutics, Santarus, Inc., Hospira, and Stroh Brewing Company. Throughout their career, Craig has demonstrated expertise in drafting regulatory submissions, managing clinical trial materials, qualifying analytical methods, and implementing quality systems.

Craig Bowe attended the University of Wisconsin-La Crosse from 1992 to 1996, where they obtained a Bachelor of Science degree in Chemistry.